z-logo
open-access-imgOpen Access
I cannot picture it in my mind: acquired aphantasia after autologous stem cell transplantation for multiple myeloma
Author(s) -
Adam L Bumgardner,
Kyle Yuan,
Alden V. Chiu
Publication year - 2021
Publication title -
oxford medical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.169
H-Index - 9
ISSN - 2053-8855
DOI - 10.1093/omcr/omab019
Subject(s) - medicine , multiple myeloma , melphalan , autologous stem cell transplantation , etiology , transplantation , stem cell , refractory (planetary science) , oncology , surgery , biology , astrobiology , physics , genetics
Aphantasia, the loss of mental imagery, is a rare disorder and even more infrequent when acquired. No previous cases have been identified that were caused by transplant-related treatment. We describe a case of acquired aphantasia in a 62-year-old male with refractory IgG kappa multiple myeloma after receiving an autologous stem cell transplant (ASCT) following high-dose melphalan with a complicated hospital admission. The etiology of aphantasia remains unidentified, but we provide viable explanations to include direct effects from ASCT treatment and indirect effects from transplant-related complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom